Summit Therapeutics (SMMT) Selling, General & Administrative (2017 - 2026)
Summit Therapeutics (SMMT) recorded Selling, General & Administrative of $62.76 million in Q2 2026, down 82.6% from $360.42 million a year earlier but up 0.3% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Selling, General & Administrative (2017 - 2026) Analysis & Trends
On a TTM basis, Summit Therapeutics' Selling, General & Administrative came in at $306.11 million as of Jun 30, 2026, down 25.5% year-over-year; for FY2025, it came in at $556.75 million, up 824.6% from FY2024.
- Annual Selling, General & Administrative has increased for six straight years, with a five-year compound annual growth rate of 96.0% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $60.21 million in FY2024 (+105.8%), $29.26 million in FY2023 (+9.4%), $26.74 million in FY2022 (+13.3%) and $23.61 million in FY2021 (+22.8%).
- Quarterly Selling, General & Administrative has ranged from $5.43 million in Q3 2023 to $360.42 million in Q2 2025 over the past five years.
- On a year-over-year basis, Selling, General & Administrative rose in six of the last seven quarters, with growth averaging 202.0%.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 445.5% in Q4 2025, against a decline of 82.6% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $62.59 million (Q1 2026), $77.63 million (Q4 2025) and $103.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Summit Therapeutics | 12.28 Bn | 10.04 Bn | - | 62.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.76 Mn |
| Mar 31, 2026 | 62.59 Mn |
| Dec 31, 2025 | 77.63 Mn |
| Sep 30, 2025 | 103.12 Mn |
| Jun 30, 2025 | 360.42 Mn |
| Mar 31, 2025 | 15.59 Mn |
| Dec 31, 2024 | 14.23 Mn |
| Sep 30, 2024 | 20.65 Mn |
| Jun 30, 2024 | 13.81 Mn |
| Mar 31, 2024 | 11.52 Mn |
| Dec 31, 2023 | 10.57 Mn |
| Sep 30, 2023 | 5.43 Mn |
| Jun 30, 2023 | 6.32 Mn |
| Mar 31, 2023 | 6.94 Mn |
| Dec 31, 2022 | 7.58 Mn |
| Sep 30, 2022 | 5.57 Mn |
| Jun 30, 2022 | 6.93 Mn |
| Mar 31, 2022 | 6.66 Mn |
| Dec 31, 2021 | 7.78 Mn |
| Sep 30, 2021 | 5.66 Mn |
API Access
Summit Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();